Myeloid compartment reprogramming through nanoparticle delivered resiquimod blocks paracrine growth support and activates phagocytosis to slow tumor progression in endogenous mouse medulloblastoma and diffuse midline glioma models
Leon McSwain, Kyoungtea Kim, Duhyeong Hwang, Chaemin Lim, Cynthia L. Winham, Jon Jacques, Hunter C. Jonus, Elias P. Rosen, Arpan Pradhan, Sudhir Pai Kasturi, Andrey P. Tikunov, Serge Yacoub, Dalia Haydar, Alexander V. Kabanov, Jessica Raper, , Marina Sokolsky‐Papkov
ResiPOx, a nanoparticle-delivered TLR7/8 agonist, reprograms tumor-associated myeloid cells to inhibit tumor growth in mouse models of medulloblastoma and diffuse midline glioma.
bioRxiv · May 8, 2026 · PreprintCancer Biology